Takeda America takes over URL Pharma
Takeda will begin the integration of URL Pharma and will right away assume responsibility for the marketing and promotion of URL’s Colcrys (colchicine) for the treatment and prevention
US-based gene therapy biotech Seawolf Therapeutics and Sanofi have signed a multi-target research partnership and exclusive licensing deal worth up to $1.2bn to develop treatments for bleeding disorders and other undisclosed indications.
The manufacturing plant produces D-Ribose, through quality fermentation and applied extraction and refinement techniques, the company said. Bioenergy Life Science president Tom VonderBrink said that the BRC accreditation